Clawbacks for the 2024 hospital pharmaceutical budget came in marginally lower than 2023’s critical levels, remaining at an ...
Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...
Mochida Pharmaceutical (TSE:4534) reported a net profit margin of 5.7%, up from 4.3% a year earlier, with earnings surging 36.5% over the past year. Despite this progress, shares currently trade at ¥3 ...
In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 ...
Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...
Terns Pharmaceuticals (TERN) is getting attention after announcing that early-stage trial results for its CML drug candidate, TERN-701, were selected for oral presentation at this year's American ...
The newly established division aims to produce 22mln units annually of cancer and immunosuppressive drugs that meet EU-GMP ...
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...
Indore (Madhya Pradesh): Under the World Bank-supported ‘RAMP (Raising and Accelerating MSMEs Performance)’ scheme, the ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...
Public-private collaboration will also be essential to secure India’s position among the top global pharma exporters. Against ...
Square Pharmaceuticals, the country's leading drug manufacturer, reported a 15% rise in consolidated net profit to Tk2,397 crore for FY25, driven by strong performances from its subsidiaries and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback